Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2019Drug Design Development and TherapyOpen Access

Epigallocatechin-3-gallate in the prevention and treatment of hepatocellular carcinoma: experimental findings and translational perspectives

View Full Paper
Ask AI
Bookmark
Share

Authors

SBSabrina BimonteIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale"VAVittorio AlbinoIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale"MPMauro PiccirilloIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bimonte et al. (2019) studied this question.

synapsesocial.com/papers/6a8384de148ed1a081d40c7ahttps://doi.org/10.2147/dddt.s180079
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1Inhibitory effect of (−)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growth2015 · 58 citations